Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2CNS 1

Conditions

Stomach Neoplasms 1Esophagitis 1Esophageal Neoplasms 1

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Heart Rate × Gastrointestinal × 1 year × Clear all
NCT05907811 2026-06-04

General Anesthesia and General Anesthesia Combined With Thoracic Epidural Anesthesia

Yuzuncu Yil University

Phase NA Completed
60 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06906887 2025-06-29

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Medical College of Wisconsin

Phase 2 Recruiting
50 enrolled
Gastrointestinal

Esophageal Neoplasms, Esophagitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡